3D model helps surgeons target cancer spread in prostate patients

NCT ID NCT07129551

Recruiting now Knowledge-focused Sponsor: Martini-Klinik am UKE GmbH Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a 3D virtual model, created from PSMA PET scans, can help surgeons better remove lymph node metastases in prostate cancer patients. About 102 participants will undergo surgery with the model used for planning and guidance. Researchers will measure how many metastases are removed, surgical precision, and patient quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: virtual 3D model
What this could lead to: If successful, this could improve how surgeons find and remove lymph node metastases, potentially leading to better cancer control and quality of life for prostate cancer patients.
What could go wrong: This is a small feasibility study (102 participants) without a control group, so results may not be generalizable. The 3D model is a navigation aid, not a new treatment, and may not improve outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER (ADENOCARCINOMA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

adenocarcinoma prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER (ADENOCARCINOMA)

Contacts and locations

Locations

Anke Renter
NOT_YET_RECRUITING

Hamburg, Free and Hanseatic City of Hamburg, 25479, Germany
Martini-Klinik
RECRUITING

Hamburg, Free and Hanseatic City of Hamburg, 20246, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.